1.Peripheral Neuron-Organoid Interaction Induces Colonic Epithelial Differentiation via Non-Synaptic Substance P Secretion
Young Hyun CHE ; In Young CHOI ; Chan Eui SONG ; Chulsoon PARK ; Seung Kwon LIM ; Jeong Hee KIM ; Su Haeng SUNG ; Jae Hoon PARK ; Sun LEE ; Yong Jun KIM
International Journal of Stem Cells 2023;16(3):269-280
Background and Objectives:
The colonic epithelial layer is a complex structure consisting of multiple cell types that regulate various aspects of colonic physiology, yet the mechanisms underlying epithelial cell differentiation during development remain unclear. Organoids have emerged as a promising model for investigating organogenesis, but achieving organ-like cell configurations within colonic organoids is challenging. Here, we investigated the biological significance of peripheral neurons in the formation of colonic organoids.
Methods:
and Results: Colonic organoids were co-cultured with human embryonic stem cell (hESC)-derived peripheralneurons, resulting in the morphological maturation of columnar epithelial cells, as well as the presence of enterochromaffin cells. Substance P released from immature peripheral neurons played a critical role in the development of colonic epithelial cells. These findings highlight the vital role of inter-organ interactions in organoid development and provide insights into colonic epithelial cell differentiation mechanisms.
Conclusions
Our results suggest that the peripheral nervous system may have a significant role in the development ofcolonic epithelial cells, which could have important implications for future studies of organogenesis and disease modeling.
2.Development of Model for 「The Survey on School Foodservice Program」
Hae Young LEE ; Bo Sook YI ; Jina CHA ; Sun Ok HAM ; Moon Kyung PARK ; Mi Nam LEE ; Hye Young KIM ; Haeng Hwa KANG ; Jin Wook KWON ; Yun Hui JEONG
Korean Journal of Community Nutrition 2019;24(1):60-76
OBJECTIVES: The purpose of this study was to develop a systematic and standardized「The Survey on School Foodservice Program」that can identify the current status of school meals on the nationwide level. METHODS: This study was carried out in six steps of the analysis of report/investigation data related to school foodservice in metropolitan and provincial offices of education, analysis of preceding research related to the actual status of school foodservice, field verification of the actual condition of the school foodservice site, development of a draft of「The Survey on School Foodservice Program」, pilot study of a draft of 「The Survey on School Foodservice Program」, and suggestions of a final model of「The Survey on School Foodservice Program」from August to December, 2017. Statistical analysis was performed for frequency analysis and descriptive analysis using the SPSS program ver. 23. RESULTS: A draft of「The Survey on School Foodservice Program」was developed by analyzing the current status of report/research data on school meals in metropolitan and provincial offices of education, analyzing the preceding research on school meals, and identifying the actual conditions at school foodservice sites. To verify the validity of the school foodservice survey questionnaire, 1,031 schools were sampled from a total of 10,251 schools and the pilot test of ‘2017 School Foodservice Survey’ was conducted. The final model of「The Survey on School Foodservice Program」consisted of 12 survey sections, 29 survey categories, and 433 survey items, and the survey cycle was set for one year and three years for each survey item. CONCLUSIONS: Based on the objective statistical data through「The Survey on School Foodservice Program」, it is possible to develop the school foodservice policy, which will help establish the reliability of the school meals.
Education
;
Humans
;
Meals
;
Pilot Projects
3.Development of Model for 「The Survey on School Foodservice Program」
Hae Young LEE ; Bo Sook YI ; Jina CHA ; Sun Ok HAM ; Moon Kyung PARK ; Mi Nam LEE ; Hye Young KIM ; Haeng Hwa KANG ; Jin Wook KWON ; Yun Hui JEONG
Korean Journal of Community Nutrition 2019;24(1):60-76
OBJECTIVES: The purpose of this study was to develop a systematic and standardized「The Survey on School Foodservice Program」that can identify the current status of school meals on the nationwide level. METHODS: This study was carried out in six steps of the analysis of report/investigation data related to school foodservice in metropolitan and provincial offices of education, analysis of preceding research related to the actual status of school foodservice, field verification of the actual condition of the school foodservice site, development of a draft of「The Survey on School Foodservice Program」, pilot study of a draft of 「The Survey on School Foodservice Program」, and suggestions of a final model of「The Survey on School Foodservice Program」from August to December, 2017. Statistical analysis was performed for frequency analysis and descriptive analysis using the SPSS program ver. 23. RESULTS: A draft of「The Survey on School Foodservice Program」was developed by analyzing the current status of report/research data on school meals in metropolitan and provincial offices of education, analyzing the preceding research on school meals, and identifying the actual conditions at school foodservice sites. To verify the validity of the school foodservice survey questionnaire, 1,031 schools were sampled from a total of 10,251 schools and the pilot test of ‘2017 School Foodservice Survey’ was conducted. The final model of「The Survey on School Foodservice Program」consisted of 12 survey sections, 29 survey categories, and 433 survey items, and the survey cycle was set for one year and three years for each survey item. CONCLUSIONS: Based on the objective statistical data through「The Survey on School Foodservice Program」, it is possible to develop the school foodservice policy, which will help establish the reliability of the school meals.
Education
;
Humans
;
Meals
;
Pilot Projects
4.The Colonoscopic Characteristics and Clinical Manifestations Associated with Lower Gastrointestinal Tract Bleeding in Patients with Chronic Kidney Disease
Kyung Jin LEE ; Ho Seok KOO ; You Sun KIM ; Jung Hwa MIN ; Soo Yeon JO ; Won Eui YOON ; Dong Hun LEE ; Jin Young KIM ; Jeong Seop MOON ; Haeng Il KOH
Korean Journal of Medicine 2019;94(4):362-370
BACKGROUND/AIMS: Patients with chronic kidney disease (CKD) have a high risk of gastrointestinal tract bleeding because of platelet dysfunction attributable to uremia, a poor blood supply, and frequent use of anticoagulant agents. We describe the colonoscopic characteristics of lower gastrointestinal tract bleeding (LGIB) in patients with CKD. METHODS: A total of 230 hospitalized patients with CKD who underwent colonoscopy because of suspected LGIB between January 2003 and August 2016 were reviewed retrospectively. We categorized CKD into five stages according to the estimated glomerular filtration rate and compared the colonoscopic findings and clinical manifestations among these five subgroups. RESULTS: Of the 230 patients with CKD suspected of LGIB, 73 (31.7%, 103 cases) were colonoscopically confirmed to exhibit LGIB. Their mean age was 65.7 ± 12.8 years, and 52.1% were female (n = 38). The most common causes of LGIB were hemorrhoidal bleeding (32 cases, 43.8%), followed by bleeding of colorectal ulcers (21 cases, 28.8%), diverticular bleeding (12 cases, 16.4%), colitis-related bleeding (12 cases, 16.4%), and angiodysplastic bleeding (12 cases, 16.4%). As the CKD stage progressed, the incidence of LGIB increased (p = 0.043). On multivariate logistic regression analysis, LGIB was more common in CKD patients with hemorrhoids (odds ratio [OR]: 4.349, 95% confidence interval [CI]: 2.043–9.256, p < 0.001) or colorectal ulcers (OR: 20.001, 95% CI: 4.780–83.686, p ℃ 0.001) and in those on hemodialysis (OR: 6.863, 95% CI: 1.140–41.308, p = 0.035). CONCLUSIONS: In CKD patients, the risk of LGIB is significantly increased by hemorrhoids, colorectal ulcers, and a positive hemodialysis status.
Anticoagulants
;
Blood Platelets
;
Colonoscopy
;
Female
;
Gastrointestinal Tract
;
Glomerular Filtration Rate
;
Hemorrhage
;
Hemorrhoids
;
Humans
;
Incidence
;
Logistic Models
;
Lower Gastrointestinal Tract
;
Renal Dialysis
;
Renal Insufficiency, Chronic
;
Retrospective Studies
;
Ulcer
;
Uremia
5.Prognostic significance of lymphovascular invasion in patients with prostate cancer treated with postoperative radiotherapy
Jae Uk JEONG ; Taek Keun NAM ; Ju Young SONG ; Mee Sun YOON ; Sung Ja AHN ; Woong Ki CHUNG ; Ick Joon CHO ; Yong Hyub KIM ; Shin Haeng CHO ; Seung Il JUNG ; Dong Deuk KWON
Radiation Oncology Journal 2019;37(3):215-223
PURPOSE: To determine prognostic significance of lymphovascular invasion (LVI) in prostate cancer patients who underwent adjuvant or salvage postoperative radiotherapy (PORT) after radical prostatectomy (RP) MATERIALS AND METHODS: A total of 168 patients with prostate cancer received PORT after RP, with a follow-up of ≥12 months. Biochemical failure after PORT was defined as prostate-specific antigen (PSA) ≥0.2 ng/mL after PORT or initiation of androgen deprivation therapy (ADT) for increasing PSA levels regardless of the value. We analyzed the clinical outcomes including survivals, failure patterns, and prognostic factors affecting the outcomes. RESULTS: In total, 120 patients (71.4%) received salvage PORT after PSA levels were >0.2 ng/mL or owing to clinical failure. The 5-year biochemical failure-free survival (BCFFS), clinical failure-free survival (CFFS), distant metastasis-free survival (DMFS), overall survival, and cause-specific survival rates were 78.3%, 94.3%, 95.0%, 95.8%, and 97.3%, respectively, during a follow-up range of 12–157 months (median: 64 months) after PORT. On multivariate analysis, PSA level of ≤1.0 ng/mL at the time of receiving PORT predicted favorable BCFFS, CFFS, and DMFS. LVI predicted worse CFFS (p = 0.004) and DMFS (p = 0.015). Concurrent and/or adjuvant ADT resulted in favorable prognosis for BCFFS (p < 0.001) and CFFS (p = 0.017). CONCLUSION: For patients with adverse pathologic findings, PORT should be initiated as early as possible after continence recovery after RP. Even after administering PORT, LVI was an unfavorable predictive factor, and further intensive adjuvant therapy should be considered for these patients.
Follow-Up Studies
;
Humans
;
Multivariate Analysis
;
Prognosis
;
Prostate
;
Prostate-Specific Antigen
;
Prostatectomy
;
Prostatic Neoplasms
;
Radiotherapy
;
Survival Rate
6.The Colonoscopic Characteristics and Clinical Manifestations Associated with Lower Gastrointestinal Tract Bleeding in Patients with Chronic Kidney Disease
Kyung Jin LEE ; Ho Seok KOO ; You Sun KIM ; Jung Hwa MIN ; Soo Yeon JO ; Won Eui YOON ; Dong Hun LEE ; Jin Young KIM ; Jeong Seop MOON ; Haeng Il KOH
Korean Journal of Medicine 2019;94(4):362-370
BACKGROUND/AIMS:
Patients with chronic kidney disease (CKD) have a high risk of gastrointestinal tract bleeding because of platelet dysfunction attributable to uremia, a poor blood supply, and frequent use of anticoagulant agents. We describe the colonoscopic characteristics of lower gastrointestinal tract bleeding (LGIB) in patients with CKD.
METHODS:
A total of 230 hospitalized patients with CKD who underwent colonoscopy because of suspected LGIB between January 2003 and August 2016 were reviewed retrospectively. We categorized CKD into five stages according to the estimated glomerular filtration rate and compared the colonoscopic findings and clinical manifestations among these five subgroups.
RESULTS:
Of the 230 patients with CKD suspected of LGIB, 73 (31.7%, 103 cases) were colonoscopically confirmed to exhibit LGIB. Their mean age was 65.7 ± 12.8 years, and 52.1% were female (n = 38). The most common causes of LGIB were hemorrhoidal bleeding (32 cases, 43.8%), followed by bleeding of colorectal ulcers (21 cases, 28.8%), diverticular bleeding (12 cases, 16.4%), colitis-related bleeding (12 cases, 16.4%), and angiodysplastic bleeding (12 cases, 16.4%). As the CKD stage progressed, the incidence of LGIB increased (p = 0.043). On multivariate logistic regression analysis, LGIB was more common in CKD patients with hemorrhoids (odds ratio [OR]: 4.349, 95% confidence interval [CI]: 2.043–9.256, p < 0.001) or colorectal ulcers (OR: 20.001, 95% CI: 4.780–83.686, p ℃ 0.001) and in those on hemodialysis (OR: 6.863, 95% CI: 1.140–41.308, p = 0.035).
CONCLUSIONS
In CKD patients, the risk of LGIB is significantly increased by hemorrhoids, colorectal ulcers, and a positive hemodialysis status.
7.Factors Associated with Rebleeding in Patients with Peptic Ulcer Bleeding: Analysis of the Korean Peptic Ulcer Bleeding (K-PUB) Study.
Joon Sung KIM ; Byung Wook KIM ; Sung Min PARK ; Ki Nam SHIM ; Seong Woo JEON ; Sang Wook KIM ; Yong Chan LEE ; Hee Seok MOON ; Si Hyung LEE ; Woon Tae JUNG ; Jin Il KIM ; Kyoung Oh KIM ; Jong Jae PARK ; Woo Chul CHUNG ; Jeong Hwan KIM ; Gwang Ho BAIK ; Jung Hwan OH ; Sun Moon KIM ; Hyun Soo KIM ; Chang Heon YANG ; Jin Tae JUNG ; Chul Hyun LIM ; Hyun Joo SONG ; Yong Sik KIM ; Gwang Ha KIM ; Jie Hyun KIM ; Jae Il CHUNG ; Jun Haeng LEE ; Min Ho CHOI ; Jong Kyoung CHOI
Gut and Liver 2018;12(3):271-277
BACKGROUND/AIMS: Rebleeding is associated with mortality in patients with peptic ulcer bleeding (PUB), and risk stratification is important for the management of these patients. The purpose of our study was to examine the risk factors associated with rebleeding in patients with PUB. METHODS: The Korean Peptic Ulcer Bleeding registry is a large prospectively collected database of patients with PUB who were hospitalized between 2014 and 2015 at 28 medical centers in Korea. We examined the basic characteristics and clinical outcomes of patients in this registry. Univariate and multivariate analyses were performed to identify the factors associated with rebleeding. RESULTS: In total, 904 patients with PUB were registered, and 897 patients were analyzed. Rebleeding occurred in 7.1% of the patients (64), and the 30-day mortality was 1.0% (nine patients). According to the multivariate analysis, the risk factors for rebleeding were the presence of co-morbidities, use of multiple drugs, albumin levels, and hematemesis/hematochezia as initial presentations. CONCLUSIONS: The presence of co-morbidities, use of multiple drugs, albumin levels, and initial presentations with hematemesis/hematochezia can be indicators of rebleeding in patients with PUB. The wide use of proton pump inhibitors and prompt endoscopic interventions may explain the low incidence of rebleeding and low mortality rates in Korea.
Hemorrhage*
;
Humans
;
Incidence
;
Korea
;
Mortality
;
Multivariate Analysis
;
Peptic Ulcer Hemorrhage
;
Peptic Ulcer*
;
Prospective Studies
;
Proton Pump Inhibitors
;
Risk Factors
8.Preventive Efficacy and Safety of Rebamipide in Nonsteroidal Anti-Inflammatory Drug-Induced Mucosal Toxicity.
Jeong Ho KIM ; Soo Heon PARK ; Chul Soo CHO ; Soo Teik LEE ; Wan Hee YOO ; Sung Kook KIM ; Young Mo KANG ; Jong Sun REW ; Yong Wook PARK ; Soo Kon LEE ; Yong Chan LEE ; Won PARK ; Don Haeng LEE
Gut and Liver 2014;8(4):371-379
BACKGROUND/AIMS: The use of proton pump inhibitors or misoprostol is known to prevent the gastrointestinal complications of nonsteroidal anti-inflammatory drugs (NSAIDs). Rebamipide is known to increase the mucosal generation of prostaglandins and to eliminate free oxygen radicals, thus enhancing the protective function of the gastric mucosa. However, it is unknown whether rebamipide plays a role in preventing NSAID-induced gastropathy. The aim of this study was to determine the effectiveness of rebamipide compared to misoprostol in preventing NSAID-induced gastrointestinal complications in patients requiring continuous NSAID treatment. METHODS: We studied 479 patients who required continuous NSAID treatment. The patients were randomly assigned to groups that received 100 mg of rebamipide three times per day or 200 microg of misoprostol three times per day for 12 weeks. The primary endpoint of the analysis was the occurrence rate of gastric ulcers, as determined by endoscopy after 12 weeks of therapy. RESULTS: Of the 479 patients in the study, 242 received rebamipide, and 237 received misoprostol. Ultimately, 44 patients (18.6%) withdrew from the misoprostol group and 25 patients (10.3%) withdrew from the rebamipide group. There was a significant difference in withdrawal rate between the two groups (p=0.0103). The per protocol analysis set was not valid because of the dropout rate of the misoprostol group; thus, the intention to treat (ITT) analysis set is the main set for the efficacy analysis in this study. After 12 weeks, the occurrence rate of gastric ulcers was similar in the rebamipide and misoprostol groups (20.3% vs 21.9%, p=0.6497) according to ITT analysis. In addition, the therapeutic failure rate was similar in the rebamipide and misoprostol groups (13.6% vs 13.1%, p=0.8580). The total severity score of the gastrointestinal symptoms was significantly lower in the rebamipide group than in the misoprostol group (p=0.0002). The amount of antacid used was significantly lower in the rebamipide group than in the misoprostol group (p=0.0258). CONCLUSIONS: Rebamipide can prevent gastric ulcers when used with NSAIDs and can decrease the gastrointestinal symptoms associated with NSAID administration. When the possibility of poor compliance and the potential adverse effects of misoprostol are considered, rebamipide appears to be a clinically effective and safe alternative.
Adult
;
Aged
;
Alanine/administration & dosage/adverse effects/*analogs & derivatives
;
Anti-Inflammatory Agents, Non-Steroidal/*adverse effects
;
Anti-Ulcer Agents/*administration & dosage/adverse effects
;
Arthritis/drug therapy
;
Butanones/adverse effects
;
Diclofenac/adverse effects/analogs & derivatives
;
Double-Blind Method
;
Drug Administration Schedule
;
Gastric Mucosa
;
Humans
;
Middle Aged
;
Misoprostol/*administration & dosage/adverse effects
;
Quinolones/*administration & dosage/adverse effects
;
Stomach Ulcer/chemically induced/*prevention & control
;
Thiazines/adverse effects
;
Thiazoles/adverse effects
;
Treatment Outcome
9.Clinical Practice Guidelines for Gastric Cancer in Korea: An Evidence-Based Approach.
Jun Haeng LEE ; Jae G KIM ; Hye Kyung JUNG ; Jung Hoon KIM ; Woo Kyoung JEONG ; Tae Joo JEON ; Joon Mee KIM ; Young Il KIM ; Keun Won RYU ; Seong Ho KONG ; Hyoung Il KIM ; Hwoon Yong JUNG ; Yong Sik KIM ; Dae Young ZANG ; Jae Yong CHO ; Joon Oh PARK ; Do Hoon LIM ; Eun Sun JUNG ; Hyeong Sik AHN ; Hyun Jung KIM
Journal of Gastric Cancer 2014;14(2):87-104
Although gastric cancer is quite common in Korea, the treatment outcome is relatively favorable compared to those in western countries. However, there are currently no Korean multidisciplinary guidelines for gastric cancer. Experts from related societies developed guidelines de novo to meet Korean circumstances and requirements, including 23 recommendation statements for diagnosis (n=9) and treatment (n=14) based on relevant key questions. The quality of the evidence was rated according to the GRADE evidence evaluation framework: the evidence levels were based on a systematic review of the literature, and the recommendation grades were classified as either strong or weak. The applicability of the guidelines was considered to meet patients' view and preferences in the context of Korea. The topics of the guidelines cover diagnostic modalities (endoscopy, endoscopic ultrasound, and radiologic diagnosis), treatment modalities (surgery, therapeutic endoscopy, chemotherapy, and radiotherapy), and pathologic evaluation. An external review of the guidelines was conducted during the finalization phase.
Diagnosis
;
Drug Therapy
;
Endoscopy
;
Korea
;
Stomach Neoplasms*
;
Treatment Outcome
;
Ultrasonography
10.Synopsis on Clinical Practice Guideline of Gastric Cancer in Korea: An Evidence-Based Approach.
Jun Haeng LEE ; Jae G KIM ; Hye Kyung JUNG ; Jung Hoon KIM ; Woo Kyoung JEONG ; Tae Joo JEON ; Joon Mee KIM ; Young Il KIM ; Keun Won RYU ; Seong Ho KONG ; Hyoung Il KIM ; Hwoon Yong JUNG ; Yong Sik KIM ; Dae Young ZANG ; Jae Yong CHO ; Joon Oh PARK ; Do Hoon LIM ; Eun Sun JUNG ; Hyeong Sik AHN ; Hyun Jung KIM
The Korean Journal of Gastroenterology 2014;63(2):66-81
Although, gastric cancer is quite common in Korea, the treatment outcome is relatively favorable compared to that of Western countries. However, there is no Korean multidisciplinary guideline for gastric cancer and thus, a guideline adequate for domestic circumstances is required. Experts from related societies developed 22 recommendation statements for the diagnosis (n=9) and treatment (n=13) based on relevant key questions. Evidence levels based on systematic review of literatures were classified as five levels from A to E, and recommendation grades were classified as either strong or weak. The topics of this guideline cover diagnostic modalities (endoscopy, endoscopic ultrasound, radiologic diagnosis), treatment modalities (surgery, therapeutic endoscopy, chemotherapy, radiotherapy) and pathologic evaluation. External review of the guideline was conducted at the finalization phase.
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Chemoradiotherapy, Adjuvant
;
Endoscopy, Gastrointestinal
;
Endosonography
;
Evidence-Based Medicine
;
Follow-Up Studies
;
Gastrectomy
;
Humans
;
Magnetic Resonance Imaging
;
Positron-Emission Tomography
;
Republic of Korea
;
Stomach Neoplasms/*diagnosis/pathology/therapy
;
Tomography, X-Ray Computed

Result Analysis
Print
Save
E-mail